Composition containing ginsenoside Rg3 and silymarin and medicine
A technology of ginsenoside and silymarin, which is applied in the field of medicine, can solve the problems of high production cost, complicated production process, and low content, and achieve the best synergistic effect, the best effect, and the effect of excellent pharmacological effects
Inactive Publication Date: 2017-03-22
上海芮范生物科技有限公司
View PDF3 Cites 2 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Ginsenoside Rg3 was first obtained from red ginseng, and its content is only 0.003%. Because of its low content, the production process is complicated, resulting in high production costs
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0022] Example 1: A composition containing ginsenoside Rg3 and silymarin, its components include 3.5 parts by weight of ginsenoside Rg3 and 6.5 parts of silymarin.
Embodiment 2
[0023] Example 2: A composition containing ginsenoside Rg3 and silymarin, its components include 6 parts by weight of ginsenoside Rg3 and 4 parts of silymarin.
Embodiment 3
[0024] Example 3: A composition containing ginsenoside Rg3 and silymarin, the components of which include 1 part of ginsenoside Rg3 and 1 part of silymarin in parts by weight.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more Abstract
The invention discloses a composition containing ginsenoside Rg3 and silymarin and medicine, and mainly relates to the technical field of medicine. The composition comprises, by weight, 3-7 parts of the ginsenoside Rg3 and 3-7 parts of the silymarin. The composition containing the ginsenoside Rg3 and the silymarin and the medicine have the beneficial effects that the ginsenoside Rg3 and the silymarin are combined according to a certain proportion, the excellent synergistic medicine efficacy is achieved, tumor cells are effectively restrained, lymphopoiesis is stimulated, and the composition and the medicine have the medicine efficacy of efficient cancer fighting and immunity boosting, and also have a health-care effect.
Description
technical field [0001] The invention relates to the technical field of medicine, in particular to a composition and medicine containing ginsenoside Rg3 and silymarin. Background technique [0002] In my country, about 1.6 million people are newly diagnosed with cancer and about 1.3 million people die from cancer every year. The incidence of cancer in the world and in my country is increasing year by year. However, cancer patients in our country still account for the majority of advanced cancer patients when they see a doctor, and they have lost the chance of radical cure such as surgery and have poor treatment effects. According to the current level of cancer death in our country, two people die of cancer every minute in the whole country, and more than 2,800 people will be killed by cancer every day, which is equivalent to the destruction of a city with a population of one million in one year. It can be seen that cancer is a common and frequently-occurring disease, which ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/704A61K31/357A61K9/08A61K9/20A61P35/00A61P37/04
CPCA61K9/0019A61K9/08A61K9/2059A61K31/357A61K31/704A61K47/183A61K2300/00
Inventor 李令仪戴睿行罗杰戴晓星李志鹏
Owner 上海芮范生物科技有限公司
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap